• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, May 23, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Compilation of research discussed at the Global Forum On Nicotine: Warsaw June 16 2018

Bioengineer by Bioengineer
June 18, 2018
in Cancer
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Reduced cravings for cigarettes: after 12-hours without a cigarette, smokers rated their craving at 68 out of 100. After smoking a cigarette this reduced to 20. With both vaping products and iQOS it fell to only 40. Independent study by University of Leuven

Thailand the worst country to be a vaper. UK the best. A survey of national organisations of nicotine consumers found Thailand, Australia and India the most restrictive countries on e-cigarette use.

Health improves for smokers who switch to vapour alternatives. A clinical study funded by PMI shows improvement in eight health measures for smokers who had used its used IQOS for six months.

Smokers switching to vapour products get health benefits comparable to entirely quitting. This clinical study looking at biomarkers in smokers switching to heat not burn vapour products. The results for IQOS and glo were similar to those found in smokers who quit. Study funded by BAT.

Hardly any youth vapers have never smoked: Study found only 0.3% of US youth who had never smoked were frequent users of e-cigarettes. Study by Konstantinos Farsalinos.

Hardly any adult vapers have never smoked. A survey of 4,058 Greek adults found 32.6% were smoking. More than half of adults (54.1%) adults had tried e-cigarettes but only 0.2% of those who had never smoked were using e-cigarettes.

Comparison of cancer potencies of e-cigarettes with tobacco smoke. "Most e-cigarette analyses indicate cancer potencies Dr Ed Stephens, St Andrews University.

###

Media Contact

Ian Gregory
[email protected]
44-793-035-2333

http://www.abzed.com/

Share12Tweet8Share2ShareShareShare2

Related Posts

Cholesterol-Dependent Cancers Require Lipid Enzymes to Harness Metabolites for Growth

May 22, 2026

Serum Urokinase Differentiates Borderline HER2 Cancers

May 22, 2026

Scientists Discover Novel Biomarker Predicting Therapy Response in Pediatric Cancers

May 22, 2026

Dana-Farber Researchers Set to Showcase Two Plenary Studies and Groundbreaking Late-Breaking Cancer Research at 2026 ASCO

May 22, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    New Study Reveals Plants Can Detect the Sound of Rain

    734 shares
    Share 293 Tweet 183
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    311 shares
    Share 124 Tweet 78
  • Research Indicates Potential Connection Between Prenatal Medication Exposure and Elevated Autism Risk

    847 shares
    Share 339 Tweet 212
  • Common Food Preservatives Associated with Elevated Blood Pressure and Increased Heart Disease Risk

    55 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Targeting S100A4–TLR4–TGF-β Axis in Diabetic Dupuytren’s

Long-Term AAV9 Gene Therapy for Spinal Muscular Atrophy

Lumacaftor/Ivacaftor Safe, Effective in Preschoolers: Study

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 83 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.